Article
Telomere Therapy for Chronic Kidney Disease
1 Sept 2022
Abstract excerpt
Chronic kidney disease (CKD) is estimated to affect almost 10% of individuals worldwide and is one of the leading causes of morbidity and mortality. Renal fibrosis, a central pathway in CKD progression (irrespective of etiology), is associated with shortened or dysfunctional telomeres in animal studies. Telomeres are specialized nucleoprotein structures located at the chromosome end that maintain genomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
